InnerPulse Inc.

Boston Scientific Corp. ’s S-ICD subcutaneous implantable defibrillator matched the performance of a conventional ICD in the EFFORTLESS registry, the first large, real-world study of the minima

A percutaneous intravascular cardioverter-defibrillator (PICD) matched a traditional ICD in a small defibrillation threshold study, and the investigators believe it could eventually be a safer alterna

A panel of leading device venture investors offers its views on how the environment has changed after the economic crisis and how in many ways the issues remain the same. by Stephen Levin While the on

, a long time investor in health care services companies, signaled its intent to invest more deeply in the device sector with the acquisition of a majority position in spinal company K2M Group Holdi